{"entity":{"type":"insider","cik":"0001421162","url":"/insider/0001421162","json_url":"/insider/0001421162.json","name":"Galen Management, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":69,"n_filings":39,"first":"2009-09-17","last":"2018-01-02","span_basis":"filed_date"},"name_variants":[{"name":"Galen Management, LLC","source":"filing","n_filings":39,"first_seen":"2009-09-17","last_seen":"2018-01-02"}],"transactions":[{"id":6464292,"accession":"0001209191-18-000346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-000346","line_url":"/filing/0001209191-18-000346#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; GALEN EMPLOYEE FUND III LP; CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN PARTNERS III L P","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2195734.0,"shares_display":"2,195,734","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":219573.4,"total_display":"219,573.40","total_whole":"219,573","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2018-01-02","scope":"insider"},{"id":4945372,"accession":"0001209191-17-053313","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-053313","line_url":"/filing/0001209191-17-053313#line-1","is_derivative":false,"issuer_cik":"0001027838","issuer_name":"TACTILE SYSTEMS TECHNOLOGY INC","issuer_ticker":"TCMD","issuer_name_source":null,"issuer_url":"/issuer/0001027838","owner_cik":null,"owner_name":"Galen Management, LLC; Galen Partners V, L.L.C.; Galen Partners International V LP; Galen Partners V LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2794500.0,"shares_display":"2,794,500","price_per_share":31.02,"price_display":"31.02","price_state":"stated","total_value":86685390.0,"total_display":"86,685,390.00","total_whole":"86,685,390","shares_owned_after":907736.0,"shares_owned_after_display":"907,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-15","filed_date":"2017-09-19","scope":"insider"},{"id":4870492,"accession":"0001209191-17-042333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-042333","line_url":"/filing/0001209191-17-042333#line-1","is_derivative":false,"issuer_cik":"0001027838","issuer_name":"TACTILE SYSTEMS TECHNOLOGY INC","issuer_ticker":"TCMD","issuer_name_source":null,"issuer_url":"/issuer/0001027838","owner_cik":null,"owner_name":"Galen Management, LLC; Galen Partners V LP; Galen Partners V, L.L.C.; Galen Partners International V LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":28.85,"price_display":"28.85","price_state":"stated","total_value":5770000.0,"total_display":"5,770,000.00","total_whole":"5,770,000","shares_owned_after":3702233.0,"shares_owned_after_display":"3,702,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-28","filed_date":"2017-06-29","scope":"insider"},{"id":5352001,"accession":"0001209191-17-041443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-041443","line_url":"/filing/0001209191-17-041443#line-1","is_derivative":false,"issuer_cik":"0001027838","issuer_name":"TACTILE SYSTEMS TECHNOLOGY INC","issuer_ticker":"TCMD","issuer_name_source":null,"issuer_url":"/issuer/0001027838","owner_cik":null,"owner_name":"Galen Management, LLC; Galen Partners V LP; Galen Partners V, L.L.C.; Galen Partners International V LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83000.0,"shares_display":"83,000","price_per_share":26.45,"price_display":"26.45","price_state":"stated","total_value":2195350.0,"total_display":"2,195,350.00","total_whole":"2,195,350","shares_owned_after":3902233.0,"shares_owned_after_display":"3,902,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-21","filed_date":"2017-06-22","scope":"insider"},{"id":4083225,"accession":"0001209191-17-039838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-039838","line_url":"/filing/0001209191-17-039838#line-1","is_derivative":false,"issuer_cik":"0001027838","issuer_name":"TACTILE SYSTEMS TECHNOLOGY INC","issuer_ticker":"TCMD","issuer_name_source":null,"issuer_url":"/issuer/0001027838","owner_cik":null,"owner_name":"Galen Partners V, L.L.C.; Galen Management, LLC; Galen Partners International V LP; Galen Partners V LP","owner_display_name":"Galen Partners V, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295455.0,"shares_display":"295,455","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":7386375.0,"total_display":"7,386,375.00","total_whole":"7,386,375","shares_owned_after":3985233.0,"shares_owned_after_display":"3,985,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-13","filed_date":"2017-06-14","scope":"insider"},{"id":4742548,"accession":"0001209191-17-037171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-037171","line_url":"/filing/0001209191-17-037171#line-1","is_derivative":false,"issuer_cik":"0001027838","issuer_name":"TACTILE SYSTEMS TECHNOLOGY INC","issuer_ticker":"TCMD","issuer_name_source":null,"issuer_url":"/issuer/0001027838","owner_cik":null,"owner_name":"Galen Partners International V LP; Galen Management, LLC; Galen Partners V LP; Galen Partners V, L.L.C.","owner_display_name":"Galen Partners International V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":4280688.0,"shares_owned_after_display":"4,280,688","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-02","scope":"insider"},{"id":9270325,"accession":"0001209191-17-032529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-032529","line_url":"/filing/0001209191-17-032529#line-1","is_derivative":false,"issuer_cik":"0001605684","issuer_name":"TACTILE SYSTEMS TECHNOLOGY INC","issuer_ticker":"TCMD","issuer_name_source":null,"issuer_url":"/issuer/0001605684","owner_cik":null,"owner_name":"Galen Management, LLC; Galen Partners International V LP; Galen Partners V LP; Galen Partners V, L.L.C.","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325000.0,"shares_display":"325,000","price_per_share":21.25,"price_display":"21.25","price_state":"stated","total_value":6906250.0,"total_display":"6,906,250.00","total_whole":"6,906,250","shares_owned_after":4480688.0,"shares_owned_after_display":"4,480,688","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-16","scope":"insider"},{"id":4904698,"accession":"0001209191-17-032368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-032368","line_url":"/filing/0001209191-17-032368#line-1","is_derivative":false,"issuer_cik":"0001027838","issuer_name":"TACTILE SYSTEMS TECHNOLOGY INC","issuer_ticker":"TCMD","issuer_name_source":null,"issuer_url":"/issuer/0001027838","owner_cik":null,"owner_name":"Galen Management, LLC; Galen Partners V LP; Galen Partners V, L.L.C.; Galen Partners International V LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":325000.0,"shares_display":"325,000","price_per_share":21.25,"price_display":"21.25","price_state":"stated","total_value":6906250.0,"total_display":"6,906,250.00","total_whole":"6,906,250","shares_owned_after":4480688.0,"shares_owned_after_display":"4,480,688","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-15","scope":"insider"},{"id":2060453,"accession":"0001209191-16-135723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-135723","line_url":"/filing/0001209191-16-135723#line-1","is_derivative":false,"issuer_cik":"0001409103","issuer_name":"Quotient Ltd","issuer_ticker":"QTNT","issuer_name_source":null,"issuer_url":"/issuer/0001409103","owner_cik":null,"owner_name":"Galen Partners V, L.L.C.; Galen Management, LLC; Galen Partners V LP; Galen Partners International V LP","owner_display_name":"Galen Partners V, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":180000.0,"shares_display":"180,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":990000.0,"total_display":"990,000.00","total_whole":"990,000","shares_owned_after":6489618.0,"shares_owned_after_display":"6,489,618","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-03","filed_date":"2016-08-05","scope":"insider"},{"id":2309792,"accession":"0001209191-16-098106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-098106","line_url":"/filing/0001209191-16-098106#line-1","is_derivative":false,"issuer_cik":"0001409103","issuer_name":"Quotient Ltd","issuer_ticker":"QTNT","issuer_name_source":null,"issuer_url":"/issuer/0001409103","owner_cik":null,"owner_name":"Galen Partners V LP; Galen Management, LLC; Galen Partners V, L.L.C.; Galen Partners International V LP","owner_display_name":"Galen Partners V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":222222.0,"shares_display":"222,222","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":1999998.0,"total_display":"1,999,998.00","total_whole":"1,999,998","shares_owned_after":6309618.0,"shares_owned_after_display":"6,309,618","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-10","filed_date":"2016-02-12","scope":"insider"},{"id":8225188,"accession":"0001209191-15-054770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-054770","line_url":"/filing/0001209191-15-054770#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P; Galen Management, LLC; GALEN PARTNERS INTERNATIONAL III L P; CLAUDIUS LLC","owner_display_name":"GALEN EMPLOYEE FUND III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":4095.0,"total_display":"4,095.00","total_whole":"4,095","shares_owned_after":10978674.0,"shares_owned_after_display":"10,978,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-17","filed_date":"2015-06-18","scope":"insider"},{"id":8225183,"accession":"0001209191-15-054770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-054770","line_url":"/filing/0001209191-15-054770#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P; Galen Management, LLC; GALEN PARTNERS INTERNATIONAL III L P; CLAUDIUS LLC","owner_display_name":"GALEN EMPLOYEE FUND III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100923.0,"shares_display":"100,923","price_per_share":1.0844,"price_display":"1.08","price_state":"stated","total_value":109440.9012,"total_display":"109,440.90","total_whole":"109,441","shares_owned_after":10982574.0,"shares_owned_after_display":"10,982,574","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-18","scope":"insider"},{"id":9269389,"accession":"0001209191-15-006524","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-006524","line_url":"/filing/0001209191-15-006524#line-3","is_derivative":false,"issuer_cik":"0001421162","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0001421162","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":0.6416,"price_display":"0.64","price_state":"stated","total_value":22456.0,"total_display":"22,456.00","total_whole":"22,456","shares_owned_after":11083497.0,"shares_owned_after_display":"11,083,497","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-26","scope":"insider"},{"id":8879215,"accession":"0001209191-15-003773","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-003773","line_url":"/filing/0001209191-15-003773#line-3","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; CLAUDIUS LLC; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":0.6416,"price_display":"0.64","price_state":"stated","total_value":22456.0,"total_display":"22,456.00","total_whole":"22,456","shares_owned_after":10957621.0,"shares_owned_after_display":"10,957,621","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-12","scope":"insider"},{"id":9269390,"accession":"0001209191-15-006524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-006524","line_url":"/filing/0001209191-15-006524#line-2","is_derivative":false,"issuer_cik":"0001421162","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0001421162","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":0.651,"price_display":"0.65","price_state":"stated","total_value":23436.0,"total_display":"23,436.00","total_whole":"23,436","shares_owned_after":11118497.0,"shares_owned_after_display":"11,118,497","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-09","filed_date":"2015-01-26","scope":"insider"},{"id":8879210,"accession":"0001209191-15-003773","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-003773","line_url":"/filing/0001209191-15-003773#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; CLAUDIUS LLC; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":0.651,"price_display":"0.65","price_state":"stated","total_value":23436.0,"total_display":"23,436.00","total_whole":"23,436","shares_owned_after":10992621.0,"shares_owned_after_display":"10,992,621","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-09","filed_date":"2015-01-12","scope":"insider"},{"id":9269391,"accession":"0001209191-15-006524","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-006524","line_url":"/filing/0001209191-15-006524#line-1","is_derivative":false,"issuer_cik":"0001421162","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0001421162","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.6018,"price_display":"0.60","price_state":"stated","total_value":60180.0,"total_display":"60,180.00","total_whole":"60,180","shares_owned_after":11154497.0,"shares_owned_after_display":"11,154,497","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-26","scope":"insider"},{"id":8879206,"accession":"0001209191-15-003773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-003773","line_url":"/filing/0001209191-15-003773#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; CLAUDIUS LLC; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.6018,"price_display":"0.60","price_state":"stated","total_value":60180.0,"total_display":"60,180.00","total_whole":"60,180","shares_owned_after":11028621.0,"shares_owned_after_display":"11,028,621","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":6356009,"accession":"0001209191-14-071984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-071984","line_url":"/filing/0001209191-14-071984#line-1","is_derivative":false,"issuer_cik":"0001409103","issuer_name":"Quotient Ltd","issuer_ticker":"QTNT","issuer_name_source":null,"issuer_url":"/issuer/0001409103","owner_cik":null,"owner_name":"Galen Management, LLC; Galen Partners International V LP; Galen Partners V, L.L.C.; Galen Partners V LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":157895.0,"shares_display":"157,895","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":1500002.5,"total_display":"1,500,002.50","total_whole":"1,500,003","shares_owned_after":5837397.0,"shares_owned_after_display":"5,837,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-28","filed_date":"2014-12-01","scope":"insider"},{"id":6735789,"accession":"0001209191-14-030432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-030432","line_url":"/filing/0001209191-14-030432#line-1","is_derivative":false,"issuer_cik":"0001409103","issuer_name":"Quotient Ltd","issuer_ticker":"QTNT","issuer_name_source":null,"issuer_url":"/issuer/0001409103","owner_cik":null,"owner_name":"Galen Partners International V LP; Galen Partners V, L.L.C.; Galen Partners V LP; Galen Management, LLC","owner_display_name":"Galen Partners International V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":2500000.0,"total_display":"2,500,000.00","total_whole":"2,500,000","shares_owned_after":5679502.0,"shares_owned_after_display":"5,679,502","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-30","filed_date":"2014-05-01","scope":"insider"},{"id":6702829,"accession":"0001209191-14-017134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-017134","line_url":"/filing/0001209191-14-017134#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":11128618.0,"shares_owned_after_display":"11,128,618","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-05","scope":"insider"},{"id":9269014,"accession":"0001209191-14-022631","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-022631","line_url":"/filing/0001209191-14-022631#line-1","is_derivative":false,"issuer_cik":"0001421162","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0001421162","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21602.0,"shares_display":"21,602","price_per_share":2.0054,"price_display":"2.01","price_state":"stated","total_value":43320.6508,"total_display":"43,320.65","total_whole":"43,321","shares_owned_after":11256998.0,"shares_owned_after_display":"11,256,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-28","filed_date":"2014-03-24","scope":"insider"},{"id":6264875,"accession":"0001209191-14-015475","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-015475","line_url":"/filing/0001209191-14-015475#line-4","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN EMPLOYEE FUND III LP; Galen Management, LLC; CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN PARTNERS III L P","owner_display_name":"GALEN EMPLOYEE FUND III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":147480.0,"shares_display":"147,480","price_per_share":2.0054,"price_display":"2.01","price_state":"stated","total_value":295756.392,"total_display":"295,756.39","total_whole":"295,756","shares_owned_after":11131118.0,"shares_owned_after_display":"11,131,118","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-28","filed_date":"2014-02-28","scope":"insider"},{"id":6264873,"accession":"0001209191-14-015475","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-015475","line_url":"/filing/0001209191-14-015475#line-3","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN EMPLOYEE FUND III LP; Galen Management, LLC; CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN PARTNERS III L P","owner_display_name":"GALEN EMPLOYEE FUND III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":192479.0,"shares_display":"192,479","price_per_share":2.0415,"price_display":"2.04","price_state":"stated","total_value":392945.8785,"total_display":"392,945.88","total_whole":"392,946","shares_owned_after":11278598.0,"shares_owned_after_display":"11,278,598","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-27","filed_date":"2014-02-28","scope":"insider"},{"id":6264870,"accession":"0001209191-14-015475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-015475","line_url":"/filing/0001209191-14-015475","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN EMPLOYEE FUND III LP; Galen Management, LLC; CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN PARTNERS III L P","owner_display_name":"GALEN EMPLOYEE FUND III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11301.0,"shares_display":"11,301","price_per_share":1.952660047783382,"price_display":"1.95","price_state":"stated","total_value":22067.0112,"total_display":"22,067.01","total_whole":"22,067","shares_owned_after":11476078.0,"shares_owned_after_display":"11,476,078","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-26","filed_date":"2014-02-28","scope":"insider","n_lines":2},{"id":6412849,"accession":"0001209191-14-014103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-014103","line_url":"/filing/0001209191-14-014103#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; CLAUDIUS LLC; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43747.0,"shares_display":"43,747","price_per_share":1.9664,"price_display":"1.97","price_state":"stated","total_value":86024.1008,"total_display":"86,024.10","total_whole":"86,024","shares_owned_after":11482379.0,"shares_owned_after_display":"11,482,379","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-24","filed_date":"2014-02-25","scope":"insider"},{"id":6412846,"accession":"0001209191-14-014103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-014103","line_url":"/filing/0001209191-14-014103#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; CLAUDIUS LLC; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":530.4,"total_display":"530.40","total_whole":"530","shares_owned_after":11526126.0,"shares_owned_after_display":"11,526,126","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-21","filed_date":"2014-02-25","scope":"insider"},{"id":6837283,"accession":"0001209191-14-012427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-012427","line_url":"/filing/0001209191-14-012427#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP; Galen Management, LLC","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":4290.0,"total_display":"4,290.00","total_whole":"4,290","shares_owned_after":11526398.0,"shares_owned_after_display":"11,526,398","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider"},{"id":4941932,"accession":"0001209191-13-048236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-048236","line_url":"/filing/0001209191-13-048236#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS INTERNATIONAL III L P; GALEN PARTNERS III L P; CLAUDIUS LLC","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":8610.0,"total_display":"8,610.00","total_whole":"8,610","shares_owned_after":11528598.0,"shares_owned_after_display":"11,528,598","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-10","filed_date":"2013-10-11","scope":"insider"},{"id":4304755,"accession":"0001209191-13-035727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-035727","line_url":"/filing/0001209191-13-035727#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS III L P; GALEN EMPLOYEE FUND III LP; Galen Management, LLC; GALEN PARTNERS INTERNATIONAL III L P","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":430000.0,"total_display":"430,000.00","total_whole":"430,000","shares_owned_after":11532798.0,"shares_owned_after_display":"11,532,798","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-02","filed_date":"2013-07-03","scope":"insider"},{"id":5479054,"accession":"0001209191-13-032999","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-032999","line_url":"/filing/0001209191-13-032999#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; GALEN PARTNERS III L P; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP; CLAUDIUS LLC","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20446.0,"shares_display":"20,446","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":43958.9,"total_display":"43,958.90","total_whole":"43,959","shares_owned_after":11732798.0,"shares_owned_after_display":"11,732,798","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-19","scope":"insider"},{"id":4565338,"accession":"0001209191-13-032295","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-032295","line_url":"/filing/0001209191-13-032295#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS INTERNATIONAL III L P; CLAUDIUS LLC; GALEN PARTNERS III L P","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27814.0,"shares_display":"27,814","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":59800.1,"total_display":"59,800.10","total_whole":"59,800","shares_owned_after":11753244.0,"shares_owned_after_display":"11,753,244","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-14","scope":"insider"},{"id":4565334,"accession":"0001209191-13-032295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-032295","line_url":"/filing/0001209191-13-032295#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS INTERNATIONAL III L P; CLAUDIUS LLC; GALEN PARTNERS III L P","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3469.0,"shares_display":"3,469","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":7631.8,"total_display":"7,631.80","total_whole":"7,632","shares_owned_after":11781058.0,"shares_owned_after_display":"11,781,058","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-12","filed_date":"2013-06-14","scope":"insider"},{"id":4601895,"accession":"0001209191-13-031650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-031650","line_url":"/filing/0001209191-13-031650#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9700.0,"shares_display":"9,700","price_per_share":2.21,"price_display":"2.21","price_state":"stated","total_value":21437.0,"total_display":"21,437.00","total_whole":"21,437","shares_owned_after":11784527.0,"shares_owned_after_display":"11,784,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-10","filed_date":"2013-06-11","scope":"insider"},{"id":4601888,"accession":"0001209191-13-031650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-031650","line_url":"/filing/0001209191-13-031650#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11796.0,"shares_display":"11,796","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":25833.24,"total_display":"25,833.24","total_whole":"25,833","shares_owned_after":11794227.0,"shares_owned_after_display":"11,794,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-07","filed_date":"2013-06-11","scope":"insider"},{"id":5222351,"accession":"0001209191-13-031238","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-031238","line_url":"/filing/0001209191-13-031238#line-3","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN PARTNERS III L P; CLAUDIUS LLC; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS INTERNATIONAL III L P","owner_display_name":"GALEN PARTNERS III L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10001.0,"shares_display":"10,001","price_per_share":2.13,"price_display":"2.13","price_state":"stated","total_value":21302.13,"total_display":"21,302.13","total_whole":"21,302","shares_owned_after":11806023.0,"shares_owned_after_display":"11,806,023","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-06","filed_date":"2013-06-07","scope":"insider"},{"id":5222343,"accession":"0001209191-13-031238","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-031238","line_url":"/filing/0001209191-13-031238#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN PARTNERS III L P; CLAUDIUS LLC; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS INTERNATIONAL III L P","owner_display_name":"GALEN PARTNERS III L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6650.0,"shares_display":"6,650","price_per_share":2.21,"price_display":"2.21","price_state":"stated","total_value":14696.5,"total_display":"14,696.50","total_whole":"14,697","shares_owned_after":11816024.0,"shares_owned_after_display":"11,816,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":5222338,"accession":"0001209191-13-031238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-031238","line_url":"/filing/0001209191-13-031238#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN PARTNERS III L P; CLAUDIUS LLC; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS INTERNATIONAL III L P","owner_display_name":"GALEN PARTNERS III L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22802.0,"shares_display":"22,802","price_per_share":2.21,"price_display":"2.21","price_state":"stated","total_value":50392.42,"total_display":"50,392.42","total_whole":"50,392","shares_owned_after":11822674.0,"shares_owned_after_display":"11,822,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-04","filed_date":"2013-06-07","scope":"insider"},{"id":4565085,"accession":"0001209191-13-030248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-030248","line_url":"/filing/0001209191-13-030248#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P; CLAUDIUS LLC","owner_display_name":"GALEN PARTNERS INTERNATIONAL III L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18699.0,"shares_display":"18,699","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":42072.75,"total_display":"42,072.75","total_whole":"42,073","shares_owned_after":11845476.0,"shares_owned_after_display":"11,845,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-31","filed_date":"2013-06-03","scope":"insider"},{"id":4565080,"accession":"0001209191-13-030248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-030248","line_url":"/filing/0001209191-13-030248#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN PARTNERS INTERNATIONAL III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS III L P; CLAUDIUS LLC","owner_display_name":"GALEN PARTNERS INTERNATIONAL III L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12860.0,"shares_display":"12,860","price_per_share":2.256,"price_display":"2.26","price_state":"stated","total_value":29012.16,"total_display":"29,012.16","total_whole":"29,012","shares_owned_after":11864175.0,"shares_owned_after_display":"11,864,175","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-30","filed_date":"2013-06-03","scope":"insider"},{"id":5300566,"accession":"0001209191-13-028548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-028548","line_url":"/filing/0001209191-13-028548#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; GALEN PARTNERS INTERNATIONAL III L P","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47410.0,"shares_display":"47,410","price_per_share":2.2986,"price_display":"2.30","price_state":"stated","total_value":108976.626,"total_display":"108,976.63","total_whole":"108,977","shares_owned_after":11877035.0,"shares_owned_after_display":"11,877,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-21","filed_date":"2013-05-23","scope":"insider"},{"id":4368011,"accession":"0001209191-13-027656","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-027656","line_url":"/filing/0001209191-13-027656#line-3","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP; Galen Management, LLC; GALEN PARTNERS III L P","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68993.0,"shares_display":"68,993","price_per_share":2.3949,"price_display":"2.39","price_state":"stated","total_value":165231.3357,"total_display":"165,231.34","total_whole":"165,231","shares_owned_after":11924445.0,"shares_owned_after_display":"11,924,445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-20","filed_date":"2013-05-20","scope":"insider"},{"id":4368007,"accession":"0001209191-13-027656","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-027656","line_url":"/filing/0001209191-13-027656#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP; Galen Management, LLC; GALEN PARTNERS III L P","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54460.0,"shares_display":"54,460","price_per_share":2.3557,"price_display":"2.36","price_state":"stated","total_value":128291.422,"total_display":"128,291.42","total_whole":"128,291","shares_owned_after":11993438.0,"shares_owned_after_display":"11,993,438","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-17","filed_date":"2013-05-20","scope":"insider"},{"id":4368000,"accession":"0001209191-13-027656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-027656","line_url":"/filing/0001209191-13-027656#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN EMPLOYEE FUND III LP; Galen Management, LLC; GALEN PARTNERS III L P","owner_display_name":"CLAUDIUS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42599.0,"shares_display":"42,599","price_per_share":2.2088,"price_display":"2.21","price_state":"stated","total_value":94092.6712,"total_display":"94,092.67","total_whole":"94,093","shares_owned_after":12047898.0,"shares_owned_after_display":"12,047,898","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-16","filed_date":"2013-05-20","scope":"insider"},{"id":4457195,"accession":"0001209191-13-026544","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-026544","line_url":"/filing/0001209191-13-026544#line-3","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN PARTNERS III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P","owner_display_name":"GALEN PARTNERS III L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23585.0,"shares_display":"23,585","price_per_share":2.2729,"price_display":"2.27","price_state":"stated","total_value":53606.3465,"total_display":"53,606.35","total_whole":"53,606","shares_owned_after":12090497.0,"shares_owned_after_display":"12,090,497","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-15","scope":"insider"},{"id":4457187,"accession":"0001209191-13-026544","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-026544","line_url":"/filing/0001209191-13-026544#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN PARTNERS III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P","owner_display_name":"GALEN PARTNERS III L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87399.0,"shares_display":"87,399","price_per_share":2.4397,"price_display":"2.44","price_state":"stated","total_value":213227.3403,"total_display":"213,227.34","total_whole":"213,227","shares_owned_after":12114082.0,"shares_owned_after_display":"12,114,082","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-15","scope":"insider"},{"id":4457183,"accession":"0001209191-13-026544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-026544","line_url":"/filing/0001209191-13-026544#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"GALEN PARTNERS III L P; Galen Management, LLC; GALEN EMPLOYEE FUND III LP; CLAUDIUS LLC; GALEN PARTNERS INTERNATIONAL III L P","owner_display_name":"GALEN PARTNERS III L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72450.0,"shares_display":"72,450","price_per_share":2.2092,"price_display":"2.21","price_state":"stated","total_value":160056.54,"total_display":"160,056.54","total_whole":"160,057","shares_owned_after":12201481.0,"shares_owned_after_display":"12,201,481","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-13","filed_date":"2013-05-15","scope":"insider"},{"id":4845110,"accession":"0001209191-13-024696","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-024696","line_url":"/filing/0001209191-13-024696#line-3","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN PARTNERS III L P; CLAUDIUS LLC; GALEN EMPLOYEE FUND III LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20887.0,"shares_display":"20,887","price_per_share":2.2335,"price_display":"2.23","price_state":"stated","total_value":46651.1145,"total_display":"46,651.11","total_whole":"46,651","shares_owned_after":12334527.0,"shares_owned_after_display":"12,334,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-07","filed_date":"2013-05-07","scope":"insider"},{"id":4845105,"accession":"0001209191-13-024696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-024696","line_url":"/filing/0001209191-13-024696#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":null,"owner_name":"Galen Management, LLC; GALEN PARTNERS INTERNATIONAL III L P; GALEN PARTNERS III L P; CLAUDIUS LLC; GALEN EMPLOYEE FUND III LP","owner_display_name":"Galen Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105300.0,"shares_display":"105,300","price_per_share":2.1234,"price_display":"2.12","price_state":"stated","total_value":223594.02,"total_display":"223,594.02","total_whole":"223,594","shares_owned_after":12355414.0,"shares_owned_after_display":"12,355,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-06","filed_date":"2013-05-07","scope":"insider"}],"collapsed":true,"next_cursor":"2013-05-06|4845105","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000786947","name":"ACURA PHARMACEUTICALS, INC","url":"/issuer/0000786947","role":"Ten percent owner, Other","n_filings":26,"first_seen":"2013-04-09","last_seen":"2018-01-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001027838","name":"TACTILE SYSTEMS TECHNOLOGY INC","url":"/issuer/0001027838","role":"Ten percent owner","n_filings":7,"first_seen":"2017-05-15","last_seen":"2017-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001596946","name":"Quotient Ltd","url":"/issuer/0001596946","role":"Ten percent owner","n_filings":4,"first_seen":"2014-05-01","last_seen":"2016-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001254419","name":"MEDASSETS INC","url":"/issuer/0001254419","role":"Other","n_filings":2,"first_seen":"2009-09-17","last_seen":"2009-10-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001421162","retrieved_at":"2026-08-27T13:37:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}